First AD

Second AD

Diagnosing and Managing Myelodysplastic Syndrome

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Insights Video Series

Advances in the Treatment and Management of Myelodysplastic Syndrome (MDS): The Role of Oral HMAs

Join Dr. Guillermo Garcia-Manero in this OncLive Insights program as he delves into the latest advancements in the treatment of myelodysplastic syndrome (MDS), with a specific focus on the emerging role of oral hypomethylating agents (HMAs). In this episode, gain insights about MDS risk stratification and prognosis, and why it is important to treat early.

Treating Intermediate- and High-Risk MDS

Available and Emerging Oral HMAs

Real-World Use for Oral HMAs

The Impact of Oral HMA Treatment Options on QOL

The Role for HMAs in Lower-Risk MDS

Treating CMML and AML with HMAs

Managing AEs Associated with HMA Treatment